| Louis I Peng, MD | |
|
18 Nw 20th Ave, Battle Ground, WA 98604-4175 | |
| (360) 952-4457 | |
| (360) 828-7409 |
| Full Name | Louis I Peng |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 18 Nw 20th Ave, Battle Ground, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831121615 | NPI | - | NPPES |
| 210837 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD20257 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Peacehealth Southwest Medical Center | Vancouver, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rose Medical Groups Pc | 9335430677 | 11 |
News Archive
Catalyst Pharmaceutical Partners, Inc. a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, today announced that it has initiated its randomized, double-blind, placebo-controlled U.S. Phase II clinical trial of CPP-109 in patients with cocaine dependence.
In its session at the World Cancer Congress, DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association explained how fragmentation within healthcare systems makes it difficult for them to effectively manage complex conditions such as cancer where the various dimensions of care - prevention, screening, diagnosis, treatment and palliation – are inseparable.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Hypnosis can serve as a valuable adjunct to certain kinds of psychotherapy, says Steven Lynn, professor of psychology at Binghamton University, State University of New York. But not everyone responds to it equally well.
› Verified 4 days ago
| Entity Name | Rose Medical Groups Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063818573 PECOS PAC ID: 9335430677 Enrollment ID: O20160616002556 |
News Archive
Catalyst Pharmaceutical Partners, Inc. a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, today announced that it has initiated its randomized, double-blind, placebo-controlled U.S. Phase II clinical trial of CPP-109 in patients with cocaine dependence.
In its session at the World Cancer Congress, DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association explained how fragmentation within healthcare systems makes it difficult for them to effectively manage complex conditions such as cancer where the various dimensions of care - prevention, screening, diagnosis, treatment and palliation – are inseparable.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Hypnosis can serve as a valuable adjunct to certain kinds of psychotherapy, says Steven Lynn, professor of psychology at Binghamton University, State University of New York. But not everyone responds to it equally well.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Louis I Peng, MD 18 Nw 20th Ave, Battle Ground, WA 98604-4175 Ph: (360) 952-4457 | Louis I Peng, MD 18 Nw 20th Ave, Battle Ground, WA 98604-4175 Ph: (360) 952-4457 |
News Archive
Catalyst Pharmaceutical Partners, Inc. a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, today announced that it has initiated its randomized, double-blind, placebo-controlled U.S. Phase II clinical trial of CPP-109 in patients with cocaine dependence.
In its session at the World Cancer Congress, DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association explained how fragmentation within healthcare systems makes it difficult for them to effectively manage complex conditions such as cancer where the various dimensions of care - prevention, screening, diagnosis, treatment and palliation – are inseparable.
Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.
Hypnosis can serve as a valuable adjunct to certain kinds of psychotherapy, says Steven Lynn, professor of psychology at Binghamton University, State University of New York. But not everyone responds to it equally well.
› Verified 4 days ago
Dr. Navin Shiva Nagaraj, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2005 W Main St, Battle Ground, WA 98604 Phone: 360-882-2778 Fax: 360-604-1762 |